| Gomintia, Injektionslösung in einer Fertigspritze 100 mg/1 ml - | | 70541002 CM | | Janssen-Cilag AG | | Gomintia, Injektionslösung in einer Fertigspritze 100 mg/1 ml | | 09.12.2025 | | | | | 09.12.2025 | | Golimumab (L04AB06) | | | | WHO-DDD | | | | | | | | 07.15. | | | | | | | | No | | | | | | | | | | | | k.A. | | | | FB | | | | 7680705410026 | | Biotechnologika | | | | |
| | Composition | | golimumabum 100 mg, sorbitolum 41 mg, polysorbatum 80, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. | | Packungsbestandteile | | | | | | Active Agent | Dose |
|---|
| Golimumabum | 100 mg/ml |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Polysorbatum 80 | | | Sorbitol | 41 mg/ml |
|
| | Source | | | |
|
|